Biomerica, Inc. (BMRA)
USD 0.51
(-4.89%)
USD 0.51
(-4.89%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 459 Thousand USD | 0.0% |
| 2023 | 785 Thousand USD | -24.39% |
| 2022 | 1.03 Million USD | -19.61% |
| 2021 | 1.29 Million USD | -17.72% |
| 2020 | 1.56 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 35.42 Thousand USD | -56.01% |
| 2009 | 80.52 Thousand USD | -29.71% |
| 2008 | 114.56 Thousand USD | 2640.79% |
| 2007 | 4180.00 USD | -51.25% |
| 2006 | 8574.00 USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 254.5 Thousand USD | -26.23% |
| 2002 | 345 Thousand USD | 263.16% |
| 2001 | 95 Thousand USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 300 Thousand USD | -66.67% |
| 1995 | 900 Thousand USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | -100.0% |
| 1992 | 100 Thousand USD | 0.0% |
| 1991 | 100 Thousand USD | -91.67% |
| 1990 | 1.2 Million USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | 459 Thousand USD | -41.53% |
| 2024 Q4 | 459 Thousand USD | 0.0% |
| 2024 Q3 | 543 Thousand USD | 0.0% |
| 2024 Q1 | 705 Thousand USD | 0.0% |
| 2024 Q2 | 626 Thousand USD | 0.0% |
| 2023 Q2 | 901.44 Thousand USD | -7.15% |
| 2023 Q1 | 970.89 Thousand USD | -6.49% |
| 2023 FY | 785 Thousand USD | -24.39% |
| 2023 Q4 | 785 Thousand USD | -5.3% |
| 2023 Q3 | 828.94 Thousand USD | -8.04% |
| 2022 Q1 | 1.23 Million USD | -4.7% |
| 2022 Q4 | 1.03 Million USD | -6.0% |
| 2022 FY | 1.03 Million USD | -19.61% |
| 2022 Q2 | 1.16 Million USD | -5.21% |
| 2022 Q3 | 1.1 Million USD | -5.33% |
| 2021 Q4 | 1.29 Million USD | -7.49% |
| 2021 FY | 1.29 Million USD | -17.72% |
| 2021 Q1 | 1.51 Million USD | -3.78% |
| 2021 Q2 | 1.45 Million USD | -3.68% |
| 2021 Q3 | 1.39 Million USD | -4.04% |
| 2020 FY | 1.56 Million USD | 0.0% |
| 2020 Q1 | 1.73 Million USD | 0.0% |
| 2020 Q2 | 1.67 Million USD | -3.06% |
| 2020 Q3 | 1.62 Million USD | -3.22% |
| 2020 Q4 | 1.56 Million USD | -3.37% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q1 | 23.62 Thousand USD | -33.3% |
| 2011 Q2 | 11.78 Thousand USD | -50.13% |
| 2011 Q3 | - USD | -100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 FY | 35.42 Thousand USD | -56.01% |
| 2010 Q3 | 47.02 Thousand USD | 0.0% |
| 2010 Q4 | 35.42 Thousand USD | -24.67% |
| 2009 Q1 | 101.52 Thousand USD | -11.39% |
| 2009 Q4 | 80.52 Thousand USD | -10.82% |
| 2009 FY | 80.52 Thousand USD | -29.71% |
| 2009 Q2 | 88.41 Thousand USD | -12.91% |
| 2009 Q3 | 90.29 Thousand USD | 2.14% |
| 2008 Q2 | 138.05 Thousand USD | 4538.98% |
| 2008 Q3 | 128.37 Thousand USD | -7.02% |
| 2008 Q4 | 114.56 Thousand USD | -10.75% |
| 2008 FY | 114.56 Thousand USD | 2640.79% |
| 2008 Q1 | 2976.00 USD | -28.8% |
| 2007 Q2 | 6632.00 USD | -12.15% |
| 2007 Q4 | 4180.00 USD | -24.17% |
| 2007 Q1 | 7549.00 USD | -11.95% |
| 2007 FY | 4180.00 USD | -51.25% |
| 2007 Q3 | 5512.00 USD | -16.89% |
| 2006 Q4 | 8574.00 USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | 262.81 Thousand USD | 0.0% |
| 2006 Q3 | - USD | -100.0% |
| 2006 FY | 8574.00 USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q3 | 76.92 Thousand USD | -67.57% |
| 2004 FY | - USD | -100.0% |
| 2004 Q2 | 237.18 Thousand USD | -9.88% |
| 2004 Q1 | 263.19 Thousand USD | 3.42% |
| 2004 Q4 | - USD | -100.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | 337.65 Thousand USD | -2.13% |
| 2003 Q2 | - USD | -100.0% |
| 2003 Q4 | 254.5 Thousand USD | 0.0% |
| 2003 FY | 254.5 Thousand USD | -26.23% |
| 2002 Q1 | 225 Thousand USD | 136.84% |
| 2002 Q2 | 260 Thousand USD | 15.56% |
| 2002 Q3 | 310 Thousand USD | 19.23% |
| 2002 Q4 | 345 Thousand USD | 11.29% |
| 2002 FY | 345 Thousand USD | 263.16% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | 95 Thousand USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 FY | 95 Thousand USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q1 | 200 Thousand USD | -33.33% |
| 1997 FY | - USD | -100.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | -100.0% |
| 1996 Q1 | 800 Thousand USD | -11.11% |
| 1996 Q4 | 300 Thousand USD | 0.0% |
| 1996 Q3 | 300 Thousand USD | -25.0% |
| 1996 FY | 300 Thousand USD | -66.67% |
| 1996 Q2 | 400 Thousand USD | -50.0% |
| 1995 Q4 | 900 Thousand USD | -10.0% |
| 1995 FY | 900 Thousand USD | 0.0% |
| 1995 Q2 | 1.1 Million USD | 0.0% |
| 1995 Q3 | 1 Million USD | -9.09% |
| 1995 Q1 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1993 Q2 | - USD | -100.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | -100.0% |
| 1993 Q1 | 100 Thousand USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 Q3 | 100 Thousand USD | 0.0% |
| 1992 Q2 | 100 Thousand USD | 0.0% |
| 1992 Q4 | 100 Thousand USD | 0.0% |
| 1992 FY | 100 Thousand USD | 0.0% |
| 1992 Q1 | 100 Thousand USD | 0.0% |
| 1991 FY | 100 Thousand USD | -91.67% |
| 1991 Q4 | 100 Thousand USD | -75.0% |
| 1991 Q3 | 400 Thousand USD | -60.0% |
| 1991 Q2 | 1 Million USD | -9.09% |
| 1991 Q1 | 1.1 Million USD | -8.33% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | 1.2 Million USD | 0.0% |
| 1990 FY | 1.2 Million USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 98.729% |
| BrainsWay Ltd. | 239 Thousand USD | -92.05% |
| Cerus Corporation | 59.79 Million USD | 99.232% |
| Envoy Medical, Inc. | 404 Thousand USD | -13.614% |
| electroCore, Inc. | 537 Thousand USD | 14.525% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -3725.0% |
| IceCure Medical Ltd | 376 Thousand USD | -22.074% |
| Inogen, Inc. | 18.27 Million USD | 97.488% |
| OrthoPediatrics Corp. | 13.45 Million USD | 96.59% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -130.653% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -26.195% |
| MaxCyte, Inc. | 17.96 Million USD | 97.446% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -730.258% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.507% |
| PAVmed Inc | 2.96 Million USD | 84.493% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 92.613% |
| RxSight, Inc. | 1.21 Million USD | 62.097% |
| Sight Sciences, Inc. | 31.7 Million USD | 98.552% |
| SI-BONE, Inc. | 36.06 Million USD | 98.727% |
| TELA Bio, Inc. | 40.51 Million USD | 98.867% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.134% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 69.822% |
| Acutus Medical, Inc. | 32.65 Million USD | 98.594% |
| Talis Biomedical Corporation | 16.78 Million USD | 97.266% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 88.653% |
| CVRx, Inc. | 30.38 Million USD | 98.489% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 54.864% |
| Bioventus Inc. | 366.99 Million USD | 99.875% |
| Venus Concept Inc. | 70.79 Million USD | 99.352% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 63.103% |
| LivaNova PLC | 568.54 Million USD | 99.919% |
| 908 Devices Inc. | 3.92 Million USD | 88.318% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.91% |
| Nemaura Medical Inc. | 3.08 Million USD | 85.134% |
| NeuroPace, Inc. | 56.95 Million USD | 99.194% |
| LENSAR, Inc. | 1.75 Million USD | 73.771% |
| Apyx Medical Corporation | 33.18 Million USD | 98.617% |
| Cutera, Inc. | 418.69 Million USD | 99.89% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 96.949% |
| BioSig Technologies, Inc. | 103 Thousand USD | -345.631% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 98.294% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 95.386% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.969% |
| Axonics, Inc. | 25.84 Million USD | 98.224% |
| Outset Medical, Inc. | 134.59 Million USD | 99.659% |
| IRIDEX Corporation | 1.75 Million USD | 73.786% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.106% |
| IRadimed Corporation | 1.61 Million USD | 71.58% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -160.795% |
| INVO Bioscience, Inc. | 6.77 Million USD | 93.226% |
| Telesis Bio, Inc. | 5.26 Million USD | 91.289% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 92.313% |
| Varex Imaging Corporation | 464.2 Million USD | 99.901% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.245% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 21.939% |
| Pulmonx Corporation | 35.08 Million USD | 98.692% |
| Dynatronics Corporation | 3.25 Million USD | 85.914% |
| Modular Medical, Inc. | 817 Thousand USD | 43.819% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -203.974% |
| Semler Scientific, Inc. | 70 Thousand USD | -555.714% |
| InMode Ltd. | 6.61 Million USD | 93.059% |
| Bruker Corporation | 1.14 Billion USD | 99.96% |
| Cytosorbents Corporation | 2.54 Million USD | 81.949% |
| DexCom, Inc. | 2.57 Billion USD | 99.982% |
| Align Technology, Inc. | 96.96 Million USD | 99.527% |
| Viveve Medical, Inc. | 5.12 Million USD | 91.042% |
| ZimVie Inc. | 508.79 Million USD | 99.91% |
| Movano Inc. | 15.00 USD | -3059900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 97.468% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.885% |
| Profound Medical Corp. | 4.97 Million USD | 90.773% |
| Insulet Corporation | 1.36 Billion USD | 99.966% |
| enVVeno Medical Corporation | 1.06 Million USD | 56.861% |
| Surmodics, Inc. | 29.4 Million USD | 98.439% |
| iCAD, Inc. | 273 Thousand USD | -68.132% |
| Nuwellis, Inc. | 221 Thousand USD | -107.692% |
| Biotricity, Inc. | 10.85 Million USD | 95.772% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 98.687% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 29.358% |
| InspireMD, Inc. | 1.03 Million USD | 55.78% |
| PAVmed Inc. | 2.96 Million USD | 84.493% |
| BIOLASE, Inc. | 13.98 Million USD | 96.718% |
| Beyond Air, Inc. | 14.72 Million USD | 96.882% |
| FONAR Corporation | 37.92 Million USD | 98.79% |
| AxoGen, Inc. | 46.6 Million USD | 99.015% |
| Vivani Medical, Inc. | 19.31 Million USD | 97.623% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 98.971% |
| Inari Medical, Inc. | 30.35 Million USD | 98.488% |
| UFP Technologies, Inc. | 28 Million USD | 98.361% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -5.749% |
| Tenon Medical, Inc. | 428 Thousand USD | -7.243% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 54.192% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 78.673% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.978% |
| Sintx Technologies, Inc. | 3.68 Million USD | 87.551% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 98.767% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 21.939% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 22.987% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.949% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.909% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 24.382% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -396.297% |
| Hyperfine, Inc. | 64 Thousand USD | -617.188% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.757% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -2.117% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -141.595% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.393% |